Moreover, existing evidence suggests a compelling role for CCL5, as it has the potential to trigger the PI3K/AKT pathway, fostering epithelial-mesenchymal transition (EMT), cellular migration, and the metastatic processes within ccRCC [30]. The gene discussed is CCL5; the disease is nonpapillary renal cell carcinoma.